Current and Future Development in Lung Cancer Diagnosis

Lung cancer is the leading cause of cancer-related deaths in North America and other developed countries. One of the reasons lung cancer is at the top of the list is that it is often not diagnosed until the cancer is at an advanced stage. Thus, the earliest diagnosis of lung cancer is crucial, especially in screening high-risk populations, such as smokers, exposure to fumes, oil fields, toxic occupational places, etc. Based on the current knowledge, it looks that there is an urgent need to identify novel biomarkers. The current diagnosis of lung cancer includes different types of imaging complemented with pathological assessment of biopsies, but these techniques can still not detect early lung cancer developments. In this review, we described the advantages and disadvantages of current methods used in diagnosing lung cancer, and we provide an analysis of the potential use of body fluids as carriers of biomarkers as predictors of cancer development and progression.

• Publication year

  2021

• Venue

  International Journal of Molecular Sciences

• Publication date

  2021-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/ijms22168661PMID 34445366PMCID 8395394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Front Line Applications and Future Directions of Immunotherapy in Small-Cell Lung Cancer

  2021cited by this paper
• Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments

  2021cited by this paper
• The Effect of Advances in Lung-Cancer Treatment on Population Mortality.

  2020influential reference
• The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design

  2020cited by this paper
• A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection

  2020cited by this paper
• ELISA-based detection of open reading frame protein 1 in patients at risk of developing lung cancer.

  2020influential reference
• Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung Cancer.

  2020cited by this paper
• Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study

  2019cited by this paper
• Biomarker Testing for Patients With Advanced Non-Small Cell Lung Cancer: Real-World Issues and Tough Choices.

  2019cited by this paper
• Association of Overexpressed MYC Gene with Altered PHACTR3 and E2F4 Genes Contributes to Non-small Cell Lung Carcinoma Pathogenesis

  2019cited by this paper
• Extracellular vesicles in biological fluids. A biomarker of exposure to cigarette smoke and treatment with chemopreventive drugs

  2019cited by this paper
• Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study

  2019cited by this paper
• Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

  2019cited by this paper
• Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma

  2019cited by this paper
• Serum and blood based biomarkers for lung cancer screening: a systematic review

  2018cited by this paper
• Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden

  2018cited by this paper
• Prevalence of clonal hematopoiesis of indeterminate potential (CHIP) measured by an ultra-sensitive sequencing assay: Exploratory analysis of the Circulating Cancer Genome Atlas (CCGA) study.

  2018cited by this paper
• Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2018cited by this paper
• Liquid biopsy and its role in an advanced clinical trial for lung cancer

  2018cited by this paper
• Use of amantadine as substrate for SSAT-1 activity as a reliable clinical diagnostic assay for breast and lung cancer

  2018cited by this paper
• Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.

  2018cited by this paper
• Tumor molecular profiling of NSCLC patients using next generation sequencing

  2017cited by this paper
• Serum and Plasma Metabolomic Biomarkers for Lung Cancer

  2017cited by this paper
• Liquid biopsies come of age: towards implementation of circulating tumour DNA

  2017influential reference
• Progress and prospects of early detection in lung cancer

  2017cited by this paper
• MYC expression correlates with PD-L1 expression in non-small cell lung cancer.

  2017cited by this paper
• Screening for lung cancer: A systematic review and meta-analysis.

  2016cited by this paper
• The metabolomic detection of lung cancer biomarkers in sputum.

  2016cited by this paper
• The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.

  2016cited by this paper
• Barriers to clinical adoption of next generation sequencing: Perspectives of a policy Delphi panel

  2016cited by this paper
• Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer

  2015cited by this paper
• Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer

  2015cited by this paper
• The detection of EpCAM+ and EpCAM– circulating tumor cells

  2015cited by this paper
• Microenvironment-Modulated Metastatic CD133+/CXCR4+/EpCAM- Lung Cancer-Initiating Cells Sustain Tumor Dissemination and Correlate with Poor Prognosis.

  2015cited by this paper
• Robbins and Cotran pathologic basis of disease

  2015cited by this paper
• Human sweat metabolomics for lung cancer screening

  2015cited by this paper
• Molecularly targeted therapies in non-small-cell lung cancer annual update 2014.

  2015cited by this paper
• Lung cancer screening: advantages, controversies, and applications.

  2014cited by this paper
• Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.

  2014cited by this paper
• Non-coding RNAs in lung cancer

  2014cited by this paper
• High‐Risk Patients

  2013cited by this paper
• Molecular sputum analysis for the diagnosis of lung cancer

  2013cited by this paper
• Chemotherapy advances in small-cell lung cancer.

  2013cited by this paper
• Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.

  2013cited by this paper
• Screening for lung cancer.

  2013cited by this paper
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

  2012cited by this paper
• Strengths and Weaknesses of Immunotherapy for Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of 12 Randomized Controlled Trials

  2012cited by this paper
• Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas

  2012cited by this paper
• Outcomes of research biopsies in phase I clinical trials: the MD anderson cancer center experience.

  2011cited by this paper
• Blood-Based Gene Expression Signatures in Non–Small Cell Lung Cancer

  2011cited by this paper
• A Gene Expression Signature from Peripheral Whole Blood for Stage I Lung Adenocarcinoma

  2011cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients.

  2011cited by this paper
• Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis.

  2010cited by this paper
• Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.

  2010cited by this paper
• The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

  2010cited by this paper
• Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy.

  2010cited by this paper
• A Meta-Analysis

  2009cited by this paper
• Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls

  2009cited by this paper
• Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease.

  2009cited by this paper
• Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.

  2009cited by this paper
• Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography

  2008cited by this paper
• Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer

  2007cited by this paper
• Mechanistic and structural analysis of human spermidine/spermine N1-acetyltransferase.

  2007cited by this paper
• Cancer epigenomics: DNA methylomes and histone-modification maps

  2007cited by this paper
• The value of sputum cytology

  2007cited by this paper
• Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer.

  2007cited by this paper
• Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients.

  2006cited by this paper
• Screening for lung cancer.

  2004cited by this paper
• Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project.

  2002cited by this paper
• Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients.

  2002cited by this paper
• Spermidine/spermine n(1)-acetyltransferase catalyzes amantadine acetylation.

  2001cited by this paper
• A randomized study of fluorescence bronchoscopy versus white-light bronchoscopy for early detection of lung cancer in high risk patients

  2000cited by this paper
• Angiogenesis and the multistage development of lung cancers.

  2000cited by this paper
• Detection of bronchial preneoplastic lesions and early lung cancer with fluorescence bronchoscopy: a study about its ambulatory feasibility under local anaesthesis.

  1999cited by this paper
• Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers.

  1998cited by this paper
• Amantadine acetylation may be effected by acetyltransferases other than NAT1 or NAT2.

  1998cited by this paper
• Early Detection of Preinvasive Lesions in High-Risk Patients: A Comparison of Conventional Flexible and Fluorescence Bronchoscopy

  1998cited by this paper
• Purification and Characterization of a Protein That Permits Early Detection of Lung Cancer

  1996cited by this paper
• Effects of polyamines, polyamine analogs, and inhibitors of protein synthesis on spermidine-spermine N1-acetyltransferase gene expression.

  1996cited by this paper
• Microsatellite alterations in plasma DNA of small cell lung cancer patients

  1996cited by this paper
• Assessment of serum CYFRA 21‐1 in lung cancer

  1996cited by this paper
• Purification and Characterization of a Protein That Permits Early Detection of Lung Cancer IDENTIFICATION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN-A2/B1 AS THE ANTIGEN FOR MONOCLONAL ANTIBODY 703D4*

  1996cited by this paper
• Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.

  1995cited by this paper
• Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

  1994cited by this paper
• CYFRA 21‐1: A new marker in lung cancer

  1993cited by this paper
• Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection.

  1988cited by this paper
• Relationship between the cellular composition of sputum and the cytologic diagnosis of lung cancer.

  1987cited by this paper
• Survival and Mortality from Lung Cancer in a Screened Population: The Johns Hopkins Study

  1986cited by this paper
• Polyamine biosynthesis and interconversion in rodent tissues.

  1982cited by this paper
• Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine.

  1981cited by this paper
• Letter: Cancer statistics.

  1976cited by this paper
• Pathologic Basis of Disease

  1974cited by this paper

• Decreased overall survival in patients with brain metastases from non-small cell lung cancer with radiotherapy dose on the neurogenic niches

  2026cites this paper
• Diagnosis model of early malignant pulmonary nodules based on clinical laboratory data.

  2026cites this paper
• C1QBP Associated With Immune Infiltration Predicts Poor Prognosis in Lung Adenocarcinoma

  2026cites this paper
• The predictive value of modified-Naples prognostic score for patients with locally advanced non-small cell lung cancer undergoing surgery after neoadjuvant chemotherapy

  2026cites this paper
• Correlation between self-regulatory fatigue and physical activity in lung cancer patients undergoing comprehensive treatment

  2026cites this paper
• Non-Small Cell Lung Cancer Treatment via Cu 9 S 8 -Mediated NIR-II Photothermal Therapy

  2026cites this paper
• Single-cell sequencing and network pharmacology coupled with molecular docking and experimental validation reveal the effects of YPFS on macrophages in stage I non-small cell lung cancer

  2026cites this paper
• Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).

  2026cites this paper
• ALDH1L2 induces resistance to chemotherapy in small cell lung cancer by inhibiting ferroptosis.

  2026cites this paper
• Integrating central-slice anatomy and MRF-mapped radiomics dynamics for lung adenocarcinoma subtyping

  2026cites this paper
• Prediction of differentiation levels in lung adenocarcinoma using peripheral blood inflammatory cytokines and tumor markers

  2026cites this paper
• Microbial Carrier‐Based Delivery of RHNO1 for Mediating NF‐κB Signaling Inhibition to Regulate Proliferation and Apoptosis in Nonsmall Cell Lung Cancer

  2026cites this paper
• The molecular mechanism of IGF2BP3 promoting the malignant progression of lung cancer

  2026cites this paper
• Aberrant sialylation in cancer: From molecular mechanisms to potential therapeutics

  2026cites this paper
• In silico design of a multi-epitope vaccine against NSCLC targeting T-cell exhaustion and metastasis: insights from RNA-seq and molecular dynamics simulation analysis

  2026cites this paper
• Analyzing expression profiling of gut microbiota-related genes across lung cancer subtypes based on electrochemical sensors: a comprehensive analysis of the immune-inflammatory axis

  2026cites this paper
• Comparative Assessment of Machine Learning Approaches for Early Lung Cancer Diagnosis

  2026cites this paper
• Research progress on long non‑coding RNAs in lung cancer (Review).

  2026influential citation
• Histone deacetylase 1 analysis as a diagnostic marker in non-small cell lung carcinoma patients

  2026cites this paper
• An Adaptive Hybrid SCSOWOA Algorithm for Generalized Multi-level Thresholding in Multi-organ Medical Image Segmentation

  2026cites this paper
• The Landscape of Clinical Trials in Never-Smoker Non-Small-Cell Lung Cancer: Registered Evidence and Persistent Gaps.

  2026cites this paper
• Multiscale Analysis of Deep Learning and Machine Learning: New Insights into the Adsorption Mechanism of VOCs Gas-Sensitive Materials.

  2026cites this paper
• Harnessing the anticancer potential of Amphiroa anceps: Folic acid-based liposomal nanocarriers for cancer cell killing in vitro.

  2026cites this paper
• Advanced breath analysis through hierarchical deep convolutional neural network for multi-cancer screening

  2026cites this paper
• LungDetectNet: a multi-task deep learning framework with enhanced detection and descriptive capabilities

  2026cites this paper
• Wavelet STC-TransUNet++: Enhanced lung cancer cell segmentation and classification in histopathological images

  2026cites this paper
• The prognostic value of miR-323b-5p in non-small cell lung cancer and its mechanism of targeting IL1A in regulating the proliferation and cell cycle of non-small cell lung cancer cells

  2026cites this paper
• Assessment of transthyretin and key biomarkers for lung cancer diagnosis

  2026cites this paper
• F-18 FDG PET/CT Characteristics of a Lung Lesion and Concomitant Findings as Histopathology Predictors: A Single-Center Experience

  2026cites this paper
• Engineered MSC-Exosomes Delivering miRNAs for Respiratory Disease Diagnostics and Therapy: Opportunities and Challenges.

  2026cites this paper
• Research on the Application of Artificial Intelligence (AI) Assisted Low Dose CT Combined with Tumor Markers for the Chance Screening of Lung Cancer in Community Physical Examination Population

  2026cites this paper
• Recruitment preferences for lung cancer screening among 4-IN-THE-LUNG-RUN participants

  2026cites this paper
• Thiol/Disulfide Homeostasis in Lung Cancer: Insights from a Clinical Study

  2026cites this paper
• Smart nanoplatforms for early detection and immune modulation in lung cancer

  2026cites this paper
• The limited protective effect of prolonged smoking cessation on postoperative outcomes in uniportal video-assisted thoracic surgery for pulmonary nodules.

  2026cites this paper
• Enhancing Diagnostic Reliability of Ex Vivo Adenocarcinoma Identification Using Minimally Processed, Heterogeneous Raman Spectra and Deep Learning

  2026cites this paper
• Dual-stage pulmonary nodule detection in CT scans via cross-layer attention and adaptive multi-scale 3D CNN

  2026cites this paper
• Development of a Radiomics-Based Machine Learning Model Utilizing CT-Guided Biopsy Images: Virtual Biopsy of Thoracic Cancers

  2026cites this paper
• Analysis of the mechanism and prognostic value of PRKCQ-AS1 in inhibiting the progression of lung adenocarcinoma via regulating the PD-1/PD-L1 pathway.

  2026cites this paper
• Optimized explainable deep learning model for lung cancer diagnosis from computed tomography images

  2026cites this paper
• Analysis and Characterization of Chondroitin/Dermatan Sulfate Composition of Lung Adenocarcinoma Tissues with Different Types of Genetic Alterations in ALK, EGFR and KRAS Oncogenes

  2025cites this paper
• Combined effect of Tislelizumab and chemotherapy on tumor control rate and prognosis in patients with small cell lung cancer

  2025cites this paper
• The value of HE4 and its combined detection on predicting recurrence and cancer death in patients with non-small cell lung cancer.

  2025cites this paper
• Diagnostic efficiency of peripheral tumor serum biomarkers in lung cancer and their correlation with clinicopathological features.

  2025cites this paper
• Safety of bronchial artery infusion immunotherapy: from comparative analysis in beagle canines to clinical validation

  2025cites this paper
• Modified Borg Scale (mBorg), the Numerical Rating Scale (NRS), and the Dyspnea- 12 Scale (D- 12): cross-scale comparison assessing the development of dyspnea in early-stage lung cancer patients

  2025cites this paper
• Progression and expansion of ALK inhibitors against NSCLC: A dual target approach.

  2025cites this paper
• Hsa_circ_0072088 promotes non-small cell lung cancer progression through modulating miR-1270/TOP2A axis

  2025cites this paper
• Exploring the anticancer potential of green synthesized Zn/Cu nanocomposites from olive leaves against lung cancer

  2025cites this paper
• YouTube Videos as an Information Source About Aerobic Exercise in Rehabilitation of Lung Cancer

  2025cites this paper
• Astragalus mongholicus and Hedyotis diffusa willd inhibit cell proliferation by attenuating the miR-582-3p-p27 signaling pathway in LUAD

  2025cites this paper
• A Rectangular Toroidal Current-Based Approach for Lung Biopsy Needle Tracking

  2025cites this paper
• Pt(IV) Complexes as Anticancer Drugs and Their Relationship with Oxidative Stress

  2025cites this paper
• Genomics and the early diagnosis of lung cancer.

  2025cites this paper
• Lung cancer-associated mesenchymal stem cells mediate chemoresistance and malignant progression of lung cancer through activating HIF-1α

  2025cites this paper
• Early potential metabolic biomarkers of T1 stage lung adenocarcinoma based on serum metabolomics

  2025cites this paper
• The application progress of PAMAM dendrimer in cancer imaging and treatment

  2025cites this paper
• Immunomodulatory Effect of Nuciferine on Benzo(a)pyrene (B[a]P)-induced Lung Cancer: A Preclinical Model

  2025cites this paper
• The clinical value of systemic immune-inflammation index (SII) and prognostic nutritional index (PNI) for predicting the occurrence of metastasis in patients with lung cancer

  2025influential citation
• ECM characterization and 3D bioprinted models of NSCLC for investigating stiffness-dependent tumor behavior and drug response

  2025cites this paper
• RNA‑binding protein MBNL1 regulates tumor growth, chemosensitivity and antitumor immunity in lung adenocarcinoma by controlling the expression of tumor suppressor RNF125

  2025cites this paper
• Tri-level lung cancer classification via deep learning based GoogleNet with computed tomography images

  2025cites this paper
• Heterogeneity of Lung Cancer: The Histopathological Diversity and Tumour Classification in the Artificial Intelligence Era

  2025cites this paper
• Recent implementations of data-independent acquisition for cancer biomarker discovery in biological fluids

  2025cites this paper
• Advancing the frontier of artificial intelligence on emerging technologies to redefine cancer diagnosis and care

  2025cites this paper
• Development of a reliable risk prognostic model for lung adenocarcinoma based on the genes related to endotheliocyte senescence

  2025cites this paper
• A Multi-Level Study on the Anti-Lung Cancer Mechanism of Peiminine, a Key Component of Fritillaria ussuriensis Maxim.: Integrating Quality Analysis, Network Pharmacology, Bioinformatics Analysis, and Experimental Validation

  2025cites this paper
• Synthetic CT image generation for CBCT-guided lung radiotherapy using a diffusion model

  2025cites this paper
• Performance Analysis and Early Detection of Lung Cancer with Spiking Neural Networks

  2025cites this paper
• LINC00892 as a Prognostic Biomarker in Lung Adenocarcinoma: Role in Immune Infiltration and EMT Suppression

  2025cites this paper
• A portable microfluidic chip device integrated with a real-time CTCs detection model for point-of-care testing of early-stage lung cancer

  2025cites this paper
• Isolation, characterization and therapeutic potentials of exosomes in lung cancer: Opportunities and challenges.

  2025cites this paper
• Arachidonic acid suppresses lung cancer cell growth and modulates lipid metabolism and the ERK/PPARγ signaling pathway

  2025cites this paper
• Increasing cisplatin exposure promotes small-cell lung cancer transformation after a shift from glucose metabolism to fatty acid metabolism

  2025cites this paper
• Diagnostic yield of rapid on-site cytology evaluation on fluoroscopic-guided transbronchial biopsy in a private hospital in Jakarta: a one-year retrospective study.

  2025cites this paper
• Computational insights into the adsorption of lung cancer biomarkers on graphene-based materials and interfacial phenomena

  2025cites this paper
• Novel erbium complex with anticancer activity against radiation resistant lung adenocarcinoma cells.

  2025cites this paper
• Nicotine promotes the progression and metastasis of non-small cell lung cancer by modulating the OTUB1-c-Myc-EZH2 axis

  2025cites this paper
• Reagentless aptamer based on the ultrasensitive and fast response electrochemical capacitive biosensor for EGFR detection in non-small cell lung cancer.

  2025cites this paper
• Organoids meet microfluidics: recent advancements, challenges, and future of organoids-on-chip

  2025cites this paper
• The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases

  2025cites this paper
• Comprehensive analysis of KRT15 in pan-cancer and verification in lung adenocarcinoma

  2025cites this paper
• Deciphering a crosstalk between biological cues and multifunctional nanocarriers in lung cancer therapy.

  2025cites this paper
• A microfluidic DNA sensor array for real-time screening of early-stage lung cancer by simultaneous detection of multiple miRNAs.

  2025cites this paper
• The role and mechanism of CHMP4C in poor prognosis and drug sensitivity of lung adenocarcinoma

  2025cites this paper
• Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study

  2025cites this paper
• Salivary Extracellular Vesicles in Detection of Cancers Other than Head and Neck: A Systematic Review

  2025cites this paper
• Historic p87 Is Diagnostic for Lung Cancer Preceding Clinical Presentation by at Least 4 Years

  2025cites this paper
• Potential role of lactylation in intrinsic immune pathways in lung cancer

  2025cites this paper
• Microwave ablation combined with α-PD-L1 enhances abscopal effect and promotes CTL activation and intratumoral homing by a cytokine network involving IFN-γ and CXCL9.

  2025cites this paper
• Targeting EGFR/PI3K/AKT/mTOR and Bax/Bcl-2/caspase3 pathways with ivermectin mediates its anticancer effects against urethane-induced non-small cell lung cancer in BALB/c mice.

  2025cites this paper
• ADH1B regulates tumor stemness by activating the cAMP/PKA/CREB1 signaling axis to inhibit recurrence and metastasis of lung adenocarcinoma.

  2025cites this paper
• TsRNA-49–73-Glu-CTC: A promising serum biomarker in non-small cell lung cancer

  2025cites this paper
• Integrating finite element analysis and machine learning for non-invasive tumor detection: a piezoelectric tactile sensor-based vibration absorber approach

  2025cites this paper
• Nutritional risk, functional decline, and symptom burden in lung cancer: a study based on PG-SGA scores and biochemical data

  2025cites this paper
• Relationships among immune cells, metabolites, and non-small cell lung cancer: a mediation Mendelian randomization study

  2025influential citation
• Automatic multiorgan segmentation in lung CBCT images using a multichannel conditional consistency diffusion model

  2025cites this paper
• Nanotechnology-assisted lung cancer diagnosis: biomarkers and imaging

  2025cites this paper
• Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer

  2025cites this paper
• A Residual Multi-task Network for Joint Classification and Regression in Medical Imaging

  2025cites this paper